ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,615, issued on Aug. 18, was assigned to Vicore Pharma AB (Stockholm).
"Selective angiotensin II receptor ligands" was invented by Tomas Fex (Molndal, Sweden), Bengt Ohlsson (Molndal, Sweden), Anders Hallberg (Uppsala, Sweden) and Mats Larhed (Uppsala, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided pharmaceutical compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, Y1, Y2, Y3 and Y4 have meanings given in the description, which compounds are useful in the treatment of autoimmune and/or fibrotic diseases, including interstitial lung diseases, such as idiopathic pulmonary fibrosis and sarcoidosis."
The patent was filed on...